$4700
Point of Care Molecular Diagnostics Market is expected to grow from USD 2.92 Billion in 2020 to USD 4.63 Billion by 2028, at a CAGR of 5.94% during the forecast period 2021-2028.
Medical tests at or near a patient's site are referred to as point-of-care diagnostics. These tests can be done outside of a clinical laboratory, and they often involve diagnoses made at a doctor's office, an ambulance, or on the field. The study of biological markers is used in molecular diagnostics, which has a wide range of applications in illness monitoring and testing, risk analysis, cancer detection, and other fields. These tests were created to help doctors identify illnesses and minimize problems by analyzing samples quickly. Microbial testing methods in the past were non-specific, time-consuming, and inefficient. Doctors now have access to highly specialized, fast, and accurate diagnostic procedures because of molecular diagnostics. Point-of-care testing is now an essential element of the diagnostics industry, with applications in emergency departments, community health centers, school health programs, and at home.
Portable devices, assays, and kits used to identify and diagnose illnesses in human samples such as throat swabs, blood, serum, and feces are examples of Point of care molecular diagnostics. Decentralized point-of-care molecular testing is replacing centralized molecular diagnostics. It is quickly gaining momentum because of its ease of use, comfort, speed of turnaround, and potential to enhance patient outcomes. It can be used to diagnose in low-resource or distant regions because of these advantages.
The factors driving the Point of Care Molecular Diagnostics market are Infectious illnesses, becoming more common. Increasing research and development funds to shorten the time it takes for molecular diagnostic testing, Pre-disease diagnostics are becoming more popular to prevent illnesses from occurring. DNA sequencing and analysis have progressed thanks to technological advances. The factors restraining the Point of Care Molecular Diagnostics market growth are Product development takes a long time, and the regulatory procedure is challenging to understand.
The primary opportunity for Point of Care Molecular Diagnostics market development is customers' shifting preferences toward home testing for control and prevention.
This study delivers a comprehensive analysis of Technology, End-user, and Application. The Technology segment includes Isothermal Amplification, Sequencing, In Situ Hybridization, PCR. The PCR segment is Leading and improving the segment's growth by delivering faster results and outcomes for better treatment (PCR). The End-user segment includes Clinics, Hospitals. The hospital segment is the leading cause of the segment's worth will be boosted by the easy availability of diagnostic goods and skilled labor in hospitals. The Application segment includes Infectious Disease, Haematology, Oncology. Infectious Disease is a leading cause of Product demand is influenced by rising demand for innovative products that allow for the early and cost-effective diagnosis of infectious diseases.
The Point of Care Molecular Diagnostics Market has been divided into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America dominated the market with 28.3% in 2020, followed by Asia-pacific. The region's leading market position is due to a technologically advanced medical framework, complex insurance, copayment systems, and substantial R&D expenditure by governments and commercial financing organizations to develop POC MDx tests. Due to rising per capita income, a large population base, a burgeoning medical sector, and growing demand for medical tourism, Asia-Pacific is anticipated to multiply throughout the projection period. In places such as Latin America and the Middle East, and Africa, the market's expansion is hampered by the high cost of molecular point-of-care diagnostics and a lack of knowledge.
Some of the notable players in the Point of Care Molecular Diagnostics market are F. Hoffmann-La Roche Ltd., Siemens Healthineers, bioMerieux, Abbott, Danaher, DiaSorin, Mindray Medical, and Sysmex. In January 2020, Mindray Medical launched the TE7 ACE POC ultrasound system to provide specific, focused solutions.
Point of Care Molecular Diagnostics Market Analysis and Forecast, by Technology
Point of Care Molecular Diagnostics Market Analysis and Forecast, by End-user
Point of Care Molecular Diagnostics Market Analysis and Forecast, by Application
Point of Care Molecular Diagnostics Market Analysis and Forecast, by region
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Technology
4.3.2. Market Attractiveness Analysis By Application
4.3.3. Market Attractiveness Analysis By End-user
4.3.4. Market Attractiveness Analysis By region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Infectious disease outbreaks are becoming more common
5.2.2. Advancements in DNA sequencing and analysis technology
5.3. Restrains
5.3.1. Long time to develop a product
5.4. Opportunities
5.4.1. Shifting preferences toward home testing for control and prevention.
6. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By Technology
6.1. Segment Overview
6.2. Isothermal Amplification
6.3. Sequencing
6.4. In Situ Hybridization
6.5. PCR
7. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By End-user
7.1. Segment Overview
7.2. Clinics
7.3. Hospitals
8. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By Application
8.1. Segment Overview
8.2. Infectious Disease
8.3. Hematology
8.4. Oncology
8.5. Others
9. Global Point of Care Molecular Diagnostics Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Point of Care Molecular Diagnostics Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Point of Care Molecular Diagnostics Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. F. Hoffmann-La Roche Ltd.
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Siemens Healthineers
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. bioMerieux
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company End-user Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Abbott
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Danaher
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. DiaSorin
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Mindray Medical
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Sysmex
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Cepheid Inc.
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Danaher Corporation
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
List of Table
1. Global Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
2. Global Isothermal Amplification, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
3. Global Sequencing, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
4. Global In Situ Hybridization, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
5. Global PCR, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
6. Global Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
7. Global Clinics, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
8. Global Hospitals, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
9. Global Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
10. Global Infectious Disease, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
11. Global Hematology, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
12. Global Oncology, Point of Care Molecular Diagnostics Market, By Region, 2018-2028 (USD Billion)
13. North America Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
14. North America Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
15. North America Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
16. U.S. Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
17. U.S. Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
18. U.S. Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
19. Canada Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
20. Canada Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
21. Canada Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
22. Mexico Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
23. Mexico Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
24. Mexico Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
25. Europe Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
26. Europe Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
27. Europe Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
28. Germany Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
29. Germany Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
30. Germany Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
31. France Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
32. France Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
33. France Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
34. U.K. Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
35. U.K. Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
36. U.K. Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
37. Italy Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
38. Italy Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
39. Italy Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
40. Spain Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
41. Spain Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
42. Spain Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
43. Asia Pacific Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
44. Asia Pacific Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
45. Asia Pacific Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
46. Japan Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
47. Japan Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
48. Japan Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
49. China Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
50. China Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
51. China Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
52. India Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
53. India Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
54. 59. India Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
55. South America Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
56. South America Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
57. South America Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
58. Brazil Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
59. Brazil Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
60. Brazil Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
61. Middle East and Africa Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
62. Middle East and Africa Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
63. Middle East and Africa Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
64. UAE Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
65. UAE Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
66. UAE Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
67. South Africa Point of Care Molecular Diagnostics Market, By Technology, 2018-2028 (USD Billion)
68. South Africa Point of Care Molecular Diagnostics Market, By End-user, 2018-2028 (USD Billion)
69. South Africa Point of Care Molecular Diagnostics Market, By Application, 2018-2028 (USD Billion)
List of Figures
1. Global Point of Care Molecular Diagnostics Market Segmentation
2. Global Point of Care Molecular Diagnostics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis By Technology
9. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis By End-user
10. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis By Application
11. Global Point of Care Molecular Diagnostics Market Attractiveness Analysis By Region
12. Global Point of Care Molecular Diagnostics Market: Dynamics
13. Global Point of Care Molecular Diagnostics Market Share by Technology (2021& 2028)
14. Global Point of Care Molecular Diagnostics Market Share by End-user (2021& 2028)
15. Global Point of Care Molecular Diagnostics Market Share by Application (2021& 2028)
16. Global Point of Care Molecular Diagnostics Market Share by Regions (2021 & 2028)
17. Global Point of Care Molecular Diagnostics Market Share by Company (2020)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
Hi John,
Thanks for the report. We've been going through it and see some good data on the market and players. –
Hi Rahul,
Thank You for the report it is good and beneficial for me.
Thank You in Advance
Dear Siddhartha,
Thank you for your fast reply. The report arrived safe and sound, evrything looks all right.
Thank you very much for your assitance and I will be looking forward to another opportunity for cooperation.
Dear Siddhartha, The report looks good, and we believe the material mix is more realistic now. It is good to know you report “Net” Manufacturing Selling Price, as that can make a difference in how we view the numbers. The reports were great and we appreciate your working with us. Thanks for all your help!
Hi Siddhartha-san, Many thanks for sending trade map with final report. Best regards,
Hello Sapna,
Thanks for the report. We've been going through it and see some good data on the market and players.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.
IND